These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 23639599)

  • 1. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea.
    Vijayvargiya P; Camilleri M; Chedid V; Carlson P; Busciglio I; Burton D; Donato LJ
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):922-929.e2. PubMed ID: 29902647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for diagnosis of bile acid malabsorption in clinical practice.
    Vijayvargiya P; Camilleri M; Shin A; Saenger A
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1232-9. PubMed ID: 23644387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
    Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.
    Camilleri M; Klee EW; Shin A; Carlson P; Li Y; Grover M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G13-26. PubMed ID: 24200957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.
    Camilleri M; Vazquez-Roque MI; Carlson P; Burton D; Wong BS; Zinsmeister AR
    Neurogastroenterol Motil; 2011 Nov; 23(11):995-9, e458. PubMed ID: 21883702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
    Rao AS; Wong BS; Camilleri M; Odunsi-Shiyanbade ST; McKinzie S; Ryks M; Burton D; Carlson P; Lamsam J; Singh R; Zinsmeister AR
    Gastroenterology; 2010 Nov; 139(5):1549-58, 1558.e1. PubMed ID: 20691689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
    Camilleri M; Carlson P; Acosta A; Busciglio I
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions.
    Deiteren A; Camilleri M; Bharucha AE; Burton D; McKinzie S; Rao AS; Zinsmeister AR
    Neurogastroenterol Motil; 2010 Apr; 22(4):415-23, e95. PubMed ID: 20025675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
    Chiba T; Kudara N; Sato M; Chishima R; Abiko Y; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial.
    Vijayvargiya P; Camilleri M; Carlson P; Nair A; Nord SL; Ryks M; Rhoten D; Burton D; Busciglio I; Lueke A; Harmsen WS; Donato LJ
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2962-2970.e6. PubMed ID: 32088296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.